Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks

• Status: Unknown status
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Recurrent ICD shocks are a serious problem in pts with ICD. Treatment failure with other antiarrhythmics and ablation are common. Dronedarone is a new antiarrhythmic drug with ion channel properties similar to amiodarone.

Several case reports have shown promising results with Dronedarone for this patient population.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rabin Medical Center
• Treatments: Amiodarone; Dronedarone

Criteria

Inclusion Criteria:

• Recurernt ICD shocks depite other antiarrhythmic drug therapy

Exclusion Criteria:

• CHF NYHA IV OR DECMPENSATED III

• PERMANENT AF

• LIVER DYSFUNCION

• CR CLEARANCE <30